HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Lethal catatonia — Clinical Guidelines

Overview

Catatonia is a neuropsychiatric syndrome characterized by motor and behavioral symptoms such as stupor, mutism, posturing, and negativism, often complicating psychiatric and medical conditions 1 3 13. It can be lethal if not promptly recognized and treated 13.

Diagnosis

Key Symptoms: Psychomotor disturbances, altered consciousness, withdrawal from the environment 1 3 13.

Differential Diagnosis: Important to rule out organic causes, including porphyria and drug-induced states 7 14.

Recommended Tests: No specific diagnostic tests; clinical evaluation and exclusion of other conditions are crucial 1 7.

Grading: ICD-11 recognizes catatonia as an independent entity, aiding in accurate diagnosis 2.

Management

First-Line Treatments:

- Electroconvulsive Therapy (ECT): Highly effective, with outcomes measured by CGI-I scores 10. - Clozapine: Considered for treatment-resistant cases, though evidence is emerging 3.

Adjunctive Treatments:

- Amobarbital Sodium: Useful for facilitating feeding in immobile patients 12. - Diazepam: Often used alongside other treatments for symptom relief 13.

Specific Drug Classes/Doses: No specific dosing recommendations provided in abstracts; individualized treatment is advised 10 12.

Special Populations

Pediatrics: Drug-induced catatonia in youths requires careful monitoring due to potential lethality 5.

Comorbidities: Consider underlying organic illnesses, especially in complex presentations 15.

Key Recommendations

Prompt Recognition and Treatment of Catatonia: Early intervention with ECT is crucial for improving outcomes (Evidence: Strong 10).

Consider Organic Causes: Thorough evaluation to exclude medical conditions mimicking catatonia is essential (Evidence: Moderate 7 14).

Use of Clozapine for Treatment-Resistant Cases: Evaluate clozapine as an option for patients unresponsive to conventional treatments (Evidence: Weak 3).

Individualized Approach for Pediatric Patients: Tailor management considering the unique risks and presentations in children (Evidence: Expert opinion 5).

References

1 Yang J, Yang H, An Z. Catatonia related to tacrolimus: a real world pharmacovigilance study of FDA adverse event reporting system (FAERS) database. Expert opinion on drug safety 2025. link 2 Hirjak D, Foucher JR, Ams M, Jeanjean LC, Kubera KM, Wolf RC et al.. The origins of catatonia - Systematic review of historical texts between 1800 and 1900. Schizophrenia research 2024. link 3 Saini A, Begum N, Matti J, Ghanem DA, Fripp L, Pollak TA et al.. Clozapine as a treatment for catatonia: A systematic review. Schizophrenia research 2024. link 4 Flink-Bochacki R, McLeod C, Lipe H, Rapkin RB, Rubin SL, Heuser CC. Is it an abortion: Classification of pregnancy-ending interventions after 24 weeks in the presence of lethal fetal anomalies. Contraception 2024. link 5 Merino D, Gérard AO, Lavrut T, Askenazy F, Thümmler S, Montastruc F et al.. Drug-related catatonia in youths: real-world insights from the WHO Safety Database. European child & adolescent psychiatry 2024. link 6 Rogers JP, Oldham MA, Fricchione G, Northoff G, Ellen Wilson J, Mann SC et al.. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. Journal of psychopharmacology (Oxford, England) 2023. link 7 Kurkjian N, Tucker P. Porphyria or Catatonia: Diagnostic Dilemma on the Medical Wards. The Journal of the Oklahoma State Medical Association 2016. link 8 Jacobs AR, Dean G, Wasenda EJ, Porsch LM, Moshier EL, Luthy DA et al.. Late termination of pregnancy for lethal fetal anomalies: a national survey of maternal-fetal medicine specialists. Contraception 2015. link 9 Engelder S, Davies K, Zeilinger T, Rutledge D. A model program for perinatal palliative services. Advances in neonatal care : official journal of the National Association of Neonatal Nurses 2012. link 10 van Waarde JA, Tuerlings JH, Verwey B, van der Mast RC. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. The journal of ECT 2010. link 11 Brough AS, Stewart F, Zackowski S. Rapid onset of stupor. Southern medical journal 2000. link 12 Lewis JL, Santos AB, Knox EP. Inducing catatonic patients to eat with daily administration of amobarbital sodium. Southern medical journal 1989. link 13 Raichman JA, Martin RL, Stillings WA. Catatonic stupor: a diagnostically non-specific but distinct syndrome. The Journal of clinical psychiatry 1981. link 14 Abrams A, Braff D, Janowsky D, Hall S, Segal D. Unresponsiveness of catatonic symptoms to naloxone. Pharmakopsychiatrie, Neuro-Psychopharmakologie 1978. link 15 Gelenberg AJ. The catatonic syndrome. Lancet (London, England) 1976. link92669-6)

Lethal catatonia